Highridge Medical Completes Strategic Divestiture
Highridge Medical, a prominent entity within the global spinal device market, has undertaken a crucial step by divesting its EBI Bone Healing Division to Avista Healthcare Partners. This significant transaction aligns with Highridge's strategic focus on its core offerings in spine solutions, reaffirming its commitment to innovation in surgical technologies.
Overview of the Transition
This divestiture represents a transformative move not just for Highridge but also indicates the growing demand for advanced medical technologies. The sale enables Highridge to concentrate resources on enhancing its existing spinal device products, thereby improving the treatment capabilities for various spine pathologies.
Leadership Perspectives on the Sale
Glen Kashuba, the CEO of EBI, expressed pride in the accomplishments achieved during his tenure. He emphasized that this transition opens avenues for EBI to enhance its impact on patient care. Kashuba pointed out that their team is committed to delivering exceptional care and innovative solutions that cater to a broader range of patients.
Mike Gallagher, Managing Director at H.I.G. Capital, highlighted the successes achieved during their partnership with EBI. Gallagher affirmed the strong foundation built by EBI’s team, which is poised to navigate future opportunities effectively. He remarked that this transaction allows for an infusion of resources back into Highridge's core business, paving the way for advancements in spine care.
Highridge Medical’s Commitment to Spine Innovations
Highridge Medical has carved out a significant presence in the medical device sector, with a strong focus on spinal care. Their dedication to collaborating with surgeons has fostered an environment of innovation aimed at delivering state-of-the-art solutions in spine surgery. As they move forward post-divestiture, the company is positioned to push boundaries and set new standards in patient outcomes.
Looking Ahead: Future Projects
The divestiture of the EBI Bone Healing Division allows Highridge to elevate its commitment to researching and developing revolutionary spine treatment alternatives. With a robust portfolio already in place, the company aims to introduce next-generation products that will redefine standards of care in spine surgery.
This strategic refocus is expected to resonate positively in the medical community, enabling healthcare professionals to leverage novel technologies that improve patient experiences and outcomes. The excitement surrounding Highridge’s future projects indicates a promising horizon for both the company and the patients it serves.
About Highridge Medical
Highridge Medical's mission is clear: to enhance the quality of spine care worldwide. With partnerships that underline their commitment to innovation, the company develops comprehensive product solutions backed by strong clinical evidence. Their offerings cater to complex spine needs while promoting minimally invasive surgical options designed to benefit both surgeons and patients alike.
About H.I.G. Capital
H.I.G. Capital is a well-regarded global alternative investment firm, operating on a scale that commands attention in the industry with approximately $70 billion in total capital under management. With its extensive resources, H.I.G. Capital invests in various sectors, providing both debt and equity, and has a track record of managing and supporting successful middle market companies.
Since its establishment, H.I.G. Capital has invested in and managed over 400 companies, demonstrating its distinctive approach to enhancing operational capabilities and fostering growth in businesses across different sectors.
Frequently Asked Questions
What is the significance of the divestiture for Highridge Medical?
The divestiture allows Highridge Medical to concentrate on enhancing its core spine solutions, facilitating greater innovation and focus on product development.
Who acquired the EBI Bone Healing Division?
The EBI Bone Healing Division was acquired by Avista Healthcare Partners, further streamlining Highridge's focus on spine-related technologies.
What future developments can we expect from Highridge Medical?
Highridge Medical is expected to introduce advanced products and solutions that will significantly improve standards and outcomes in spine surgery.
How does this transaction impact EBI?
This transition offers EBI an opportunity to enhance its market reach while continuing to deliver proven bone healing technologies.
What role does H.I.G. Capital play in Highridge Medical?
H.I.G. Capital, as the parent company, supports Highridge Medical's initiatives by providing necessary investment and strategic guidance to drive growth in the spinal device market.
